Forbes January 10, 2025
Bruce Japsen

Walgreens improving retail pharmacy business and comments from the company’s chief executive are convincing Wall Street that the drugstore chain is unlikely headed for a buyout from private equity.

The fiscal first quarter earnings unveiled Friday, which showed a wider net loss than a year ago but several operating improvements across company businesses, comes following a three-byline report a month ago in the Wall Street Journal that Walgreens is considering a sale to private equity firm Sycamore Partners.

Walgreens continues to discount that report, saying executives don’t comment on rumors or speculation. The potential for a buyout wasn’t even addressed by Walgreens CEO Tim Wentworth during a call with Wall Street analysts and investors Friday.

“In U.S. pharmacy, we maintained...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Pharma, Pharma / Biotech
Q&A: Nutritional Pharmacist's Perspective on New Year Dieting Trends
Walgreens CEO: ‘Turnaround Will Take Time’
What to expect in US healthcare in 2025 and beyond
The Future of Pharmacy: Trends, Threats, Transformations
Digital Retail Platforms: The new concept of Pharma to sell directly to patients

Share This Article